MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 04-13-2026
Country |
 USA |
IPO year |
- |
Industry |
Diagnostics research |
Stock Exchange |
NASDAQ CAPITAL |
Shares |
2.3 M |
Market Cap[1] |
$ 5.58 M |
EBITDA (LTM) |
$ -4.96 M |
P/E (LTM) |
-1.53 |
P/S (LTM) |
1.07 |
EPS (LTM) |
-1.43 |
Other stocks of industry "Diagnostics research"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Castle Biosciences
CSTL
|
$ 20.36 | -0.85 % | $ 590 M | Nasdaq Global Market,SPB | USA |
 |
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market |  Germany |
 |
Fulgent Genetics
FLGT
|
$ 17.05 | -1.9 % | $ 516 M | Nasdaq Global Market | USA |
 |
Guardant Health
GH
|
$ 118.87 | 0.73 % | $ 14.9 B | Nasdaq Global Select Market,SPB | USA |
 |
ICON Public Limited Company
ICLR
|
$ 116.28 | -0.25 % | $ 9.59 B | Nasdaq Global Select Market,SPB |  Irlanda |
 |
Agilent Technologies
A
|
$ 115.04 | 0.22 % | $ 35 B | NYSE,SPB | USA |
 |
Illumina
ILMN
|
$ 144.68 | -0.1 % | $ 23 B | Nasdaq Global Select Market,SPB | USA |
 |
Celcuity
CELC
|
$ 140.47 | -1.45 % | $ 6.57 B | Nasdaq Global Select Market | USA |
 |
Co-Diagnostics
CODX
|
$ 4.42 | 19.14 % | $ 5.88 M | Nasdaq Capital Market | USA |
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market |  Canada |
 |
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | USA |
 |
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | USA |
 |
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market |  Britain |
 |
CareDx, Inc
CDNA
|
$ 21.87 | 1.39 % | $ 1.17 B | Nasdaq Global Market,SPB | USA |
 |
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | USA |
 |
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market |  Israel |
 |
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | USA |
 |
Interpace Biosciences
IDXG
|
$ 1.82 | 1.11 % | $ 8.05 M | Nasdaq Global Select Market | USA |
 |
Lantheus Holdings
LNTH
|
$ 94.3 | -0.18 % | $ 6.36 B | Nasdaq Global Select Market,SPB | USA |
 |
Medpace Holdings
MEDP
|
$ 432.38 | 0.53 % | $ 12.5 B | Nasdaq Global Select Market,SPB | USA |
 |
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE |  China |
 |
Mettler-Toledo International
MTD
|
$ 1 103.99 | 1.23 % | $ 22.8 B | NYSE,SPB |  Schweiz |
 |
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | USA |
 |
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market |  Australia |
 |
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | China |
 |
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | USA |
 |
Personalis
PSNL
|
$ 8.62 | 4.48 % | $ 769 M | Nasdaq Global Select Market | USA |
 |
Charles River Laboratories International
CRL
|
$ 160.22 | 0.81 % | $ 7.94 B | NYSE,SPB | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | USA |
 |
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | USA |
 |
NeoGenomics
NEO
|
$ 9.26 | 1.65 % | $ 1.19 B | Nasdaq Global Select Market,SPB | USA |
 |
Exact Sciences Corporation
EXAS
|
- | - | $ 19.8 B | Nasdaq Capital Market,SPB | USA |
 |
National Research Corporation
NRC
|
$ 18.92 | -0.66 % | $ 423 M | Nasdaq Global Select Market | USA |
 |
Natera
NTRA
|
$ 205.73 | 1.0 % | $ 20.2 B | Nasdaq Global Select Market,SPB | USA |
 |
Myriad Genetics
MYGN
|
$ 3.84 | -1.92 % | $ 356 M | Nasdaq Global Select Market,SPB | USA |
 |
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | USA |
 |
Koninklijke Philips N.V.
PHG
|
$ 27.07 | -0.26 % | $ 25.7 B | NYSE |  Niderland |
 |
Twist Bioscience Corporation
TWST
|
$ 60.85 | 3.42 % | $ 3.64 B | Nasdaq Global Select Market,SPB | USA |
 |
Senseonics Holdings
SENS
|
$ 6.41 | 4.06 % | $ 267 M | NYSE American | USA |
 |
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE | Niderland |
 |
Soleno Therapeutics
SLNO
|
- | - | $ 2.69 B | Nasdaq Capital Market | USA |
 |
Laboratory Corporation of America Holdings
LH
|
$ 260.35 | 1.87 % | $ 21.7 B | NYSE,SPB | USA |
 |
Waters Corporation
WAT
|
$ 342.67 | 0.54 % | $ 20.4 B | NYSE,SPB | USA |
 |
Thermo Fisher Scientific
TMO
|
$ 448.17 | -0.27 % | $ 169 B | NYSE,SPB | USA |
 |
Trinity Biotech plc
TRIB
|
$ 0.61 | -2.43 % | $ 219 M | Nasdaq Global Select Market | Irlanda |
 |
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | Israel |
 |
Neogen Corporation
NEOG
|
$ 9.07 | 2.31 % | $ 1.97 B | Nasdaq Global Select Market,SPB | USA |
 |
Exagen
XGN
|
$ 4.24 | -0.82 % | $ 91.4 M | Nasdaq Global Market | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.